Invesco
CALA

Invesco’s Calithera Biosciences, Inc CALA Stock Holding History

Invesco’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-755
Closed -$37K – 4082
2021
Q1 		$37K Buy
755
+133
+21% +$7.74K ﹤0.01% 3841
2020
Q4 		$62K Buy
+622
New +$54.5K ﹤0.01% 3719
2018
Q1 		– Sell
-8,722
Closed -$1.46M – 3791
2017
Q4 		$1.46M Buy
8,722
+1,082
+14% +$277K ﹤0.01% 2797
2017
Q3 		$2.41M Buy
+7,640
New +$2.41M ﹤0.01% 2437
2015
Q3 		– Sell
-31
Closed -$4K – 4083
2015
Q2 		$4K Buy
+31
New +$7.19K ﹤0.01% 4298

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco's CALA Position: Q2 2021 in Review

Invesco sold out of Calithera Biosciences, Inc (CALA) in Q2 2021, closing a stake of 755 shares — an estimated $37K sold.

Invesco first reported a position in CALA in Q2 2015 and held it in 5 quarters. The position peaked at $2.41M in Q3 2017. 76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

  • Invesco reported no remaining Calithera Biosciences, Inc position as of Q2 2021 after selling out during the quarter.
  • Invesco sold 755 Calithera Biosciences, Inc shares in Q2 2021, an estimated $37K.
  • Invesco first reported a position in Calithera Biosciences, Inc in Q2 2015 and held it in 5 quarters.
  • Invesco's Calithera Biosciences, Inc position peaked at $2.41M in Q3 2017.
  • 76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.